These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Yin XM, Oltvai ZN, Korsmeyer SJ. Nature; 1994 May 26; 369(6478):321-3. PubMed ID: 8183370 [Abstract] [Full Text] [Related]
3. Bifunctional apoptosis inhibitor (BAR) protects neurons from diverse cell death pathways. Roth W, Kermer P, Krajewska M, Welsh K, Davis S, Krajewski S, Reed JC. Cell Death Differ; 2003 Oct 26; 10(10):1178-87. PubMed ID: 14502241 [Abstract] [Full Text] [Related]
4. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, Tsujimoto Y. Oncogene; 1996 May 16; 12(10):2045-50. PubMed ID: 8668329 [Abstract] [Full Text] [Related]
5. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Schwarze MM, Hawley RG. Cancer Res; 1995 Jun 01; 55(11):2262-5. PubMed ID: 7757973 [Abstract] [Full Text] [Related]
6. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Semin Cancer Biol; 1993 Dec 01; 4(6):327-32. PubMed ID: 8142617 [Abstract] [Full Text] [Related]
7. Pro-apoptotic activity of transiently expressed BCL-2 occurs independent of BAX and BAK. Subramanian T, Chinnadurai G. J Cell Biochem; 2003 Aug 15; 89(6):1102-14. PubMed ID: 12898509 [Abstract] [Full Text] [Related]
8. bcl-w, a novel member of the bcl-2 family, promotes cell survival. Gibson L, Holmgreen SP, Huang DC, Bernard O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM, Cory S. Oncogene; 1996 Aug 15; 13(4):665-75. PubMed ID: 8761287 [Abstract] [Full Text] [Related]
9. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926 [Abstract] [Full Text] [Related]
10. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. Huang DC, O'Reilly LA, Strasser A, Cory S. EMBO J; 1997 Aug 01; 16(15):4628-38. PubMed ID: 9303307 [Abstract] [Full Text] [Related]
11. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Gauthier ER, Piché L, Lemieux G, Lemieux R. Cancer Res; 1996 Mar 15; 56(6):1451-6. PubMed ID: 8640839 [Abstract] [Full Text] [Related]
12. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Reed JC. Behring Inst Mitt; 1996 Oct 15; (97):72-100. PubMed ID: 8950468 [Abstract] [Full Text] [Related]
13. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells. Lindenboim L, Yuan J, Stein R. Oncogene; 2000 Mar 30; 19(14):1783-93. PubMed ID: 10777212 [Abstract] [Full Text] [Related]
14. Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Wang X, Studzinski GP. Exp Cell Res; 1997 Aug 25; 235(1):210-7. PubMed ID: 9281370 [Abstract] [Full Text] [Related]
15. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Benito A, Grillot D, Nuñez G, Fernández-Luna JL. Am J Pathol; 1995 Feb 25; 146(2):481-90. PubMed ID: 7856757 [Abstract] [Full Text] [Related]
16. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, Tsujimoto Y. Oncogene; 1996 Jul 04; 13(1):21-9. PubMed ID: 8700549 [Abstract] [Full Text] [Related]
17. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation. Schmitt E, Sané AT, Steyaert A, Cimoli G, Bertrand R. Biochem Cell Biol; 1997 Jul 04; 75(4):301-14. PubMed ID: 9493953 [Abstract] [Full Text] [Related]
18. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Tang DG, Li L, Chopra DP, Porter AT. Cancer Res; 1998 Aug 01; 58(15):3466-79. PubMed ID: 9699682 [Abstract] [Full Text] [Related]
20. Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases. Zhang H, Hoang T, Saeed B, Ng SC. Prostate; 1996 Aug 01; 29(2):69-76. PubMed ID: 8700802 [Abstract] [Full Text] [Related] Page: [Next] [New Search]